Prophylactic Eculizumab after Renal Transplantationin Atypical Hemolytic-Uremic Syndrome.

被引：113
|
作者：
Zimmerhackl, Lothar Bernd [1 ]
Hofer, Johannes [1 ]
Cortina, Gerard [1 ]
Mark, Walter [1 ]
Wuerzner, Reinhard [1 ]
Jungraithmayr, Therese C. [1 ]
Khursigara, Gus [2 ]
Kliche, Kay O. [2 ]
Radauer, Wolfgang [3 ]
机构：
[1] Med Univ Innsbruck, Innsbruck, Austria
[2] Alex Pharmaceut, Cheshire, CT USA
[3] Childrens Hosp Salzburg, Salzburg, Austria
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2010年 / 362卷 / 18期
关键词：
D O I：
10.1056/NEJMc1001060
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1746 / 1748
页数：3
相关论文
共 50 条
  • [1] Eculizumab for Atypical Hemolytic-Uremic Syndrome.
    Nuernberger, Jens
    Witzke, Oliver
    Saez, Anabelle Opazo
    Vester, Udo
    Baba, Hideo Andreas
    Kribben, Andreas
    Zimmerhackl, Lothar Bernd
    Janecke, Andreas R.
    Nagel, Mato
    Kirschfink, Michael
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05): : 542 - 544
  • [2] Eculizumab for Congenital Atypical Hemolytic-Uremic Syndrome.
    Gruppo, Ralph A.
    Rother, Russell P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05): : 544 - 546
  • [3] Eculizumab in Atypical Hemolytic-Uremic Syndrome
    Ring, Troels
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1377 - 1378
  • [4] Eculizumab in Atypical Hemolytic-Uremic Syndrome Reply
    Legendre, Christophe M.
    Licht, Christoph
    Loirat, Chantal
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1379 - 1380
  • [5] Efficacy of Eculizumab in the Treatment of Recurrent Atypical Hemolytic-Uremic Syndrome After Renal Transplantation
    Fernandez-de Larrea, Carlos
    Cofan, Frederic
    Oppenheimer, Federico
    Maria Campistol, Josep
    Escolar, Gines
    Lozano, Miguel
    [J]. TRANSPLANTATION, 2010, 89 (07) : 903 - 904
  • [6] Eculizumab for atypical hemolytic-uremic syndrome. How long should we maintain it?
    Naranjo Munoz, Javier
    Garcia Garcia-Doncel, Ana
    Montero Escobar, Maria Elisa
    Villanego Fernandez, Florentino
    Millan Ortega, Irene
    Ceballos Guerrero, Manuel
    [J]. NEFROLOGIA, 2019, 39 (04): : 440 - 442
  • [7] More on Eculizumab for Congenital Atypical Hemolytic-Uremic Syndrome
    Shin, Jae Il
    Lee, Jae Seung
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (20): : 2142 - 2143
  • [8] Atypical hemolytic-uremic syndrome due to scleroderma renal crisis treated with eculizumab
    Skonieczny, Piotr
    Wojteczek, Anna
    Zdrojewski, Zbigniew
    Debska-Slizien, Alicja
    [J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2023, 133 (02):
  • [9] More on Eculizumab for Congenital Atypical Hemolytic-Uremic Syndrome Reply
    Gruppo, Ralph A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (20): : 2143 - 2143
  • [10] Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
    Legendre, C. M.
    Licht, C.
    Muus, P.
    Greenbaum, L. A.
    Babu, S.
    Bedrosian, C.
    Bingham, C.
    Cohen, D. J.
    Delmas, Y.
    Douglas, K.
    Eitner, F.
    Feldkamp, T.
    Fouque, D.
    Furman, R. R.
    Gaber, O.
    Herthelius, M.
    Hourmant, M.
    Karpman, D.
    Lebranchu, Y.
    Mariat, C.
    Menne, J.
    Moulin, B.
    Nuernberger, J.
    Ogawa, M.
    Remuzzi, G.
    Richard, T.
    Sberro-Soussan, R.
    Severino, B.
    Sheerin, N. S.
    Trivelli, A.
    Zimmerhackl, L. B.
    Goodship, T.
    Loirat, C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (23): : 2169 - 2181
12345